Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 12:22 pm Purchase | 2024-12-31 | 13G | Dyne Therapeutics, Inc. DYN | JANUS HENDERSON GROUP PLC JHG | 7,379,309 7.300% | 566,146 (+8.31%) | Filing History |
| 2025-02-14 09:00 am Sale | 2024-12-31 | 13G | Dyne Therapeutics, Inc. DYN | RTW INVESTMENTS LP | 5,218,641 5.100% | -1,600,000 (-23.47%) | Filing History |
| 2025-02-12 09:28 am Sale | 2024-12-31 | 13G | Dyne Therapeutics, Inc. DYN | FMR LLC | 7,996,931 7.900% | -1,029,766 (-11.41%) | Filing History |
| 2025-02-03 5:07 pm Purchase | 2025-01-31 | 13G | Dyne Therapeutics, Inc. DYN | Point72 Asset Management L.P. | 5,196,597 5.100% | 5,196,597 (New Position) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN | RA CAPITAL MANAGEMENT L.P. | 6,381,144 6.400% | 1,167,483 (+22.39%) | Filing History |
| 2024-11-14 4:32 pm Sale | 2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN | Atlas Venture Fund XI, L.P. | 5,714,057 5.700% | -1,628,026 (-22.17%) | Filing History |
| 2024-11-14 4:23 pm Sale | 2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN | CITADEL ADVISORS LLC | 2,960,081 3.000% | -112,506 (-3.66%) | Filing History |
| 2024-11-14 10:28 am Purchase | 2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN | JANUS HENDERSON GROUP PLC JHG | 6,813,163 6.800% | 6,813,163 (New Position) | Filing History |
| 2024-11-14 09:27 am Purchase | 2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN | Deep Track Capital LP | 3,282,000 3.270% | 1,282,000 (+64.10%) | Filing History |
| 2024-11-14 07:00 am Sale | 2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN | Forbion Capital Fund IV Cooperatief U.A. | 5,795,364 5.800% | -335,715 (-5.48%) | Filing History |
| 2024-11-14 06:34 am Purchase | 2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN | RTW INVESTMENTS LP | 6,818,641 6.800% | 6,818,641 (New Position) | Filing History |
| 2024-11-12 2:20 pm Unchanged | 2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN | VANGUARD GROUP INC | 6,864,137 6.830% | 0 (Unchanged) | Filing History |
| 2024-11-12 09:55 am Purchase | 2024-11-08 | 13G | Dyne Therapeutics, Inc. DYN | FMR LLC | 9,026,697 8.990% | 9,026,697 (New Position) | Filing History |
| 2024-11-08 5:31 pm Unchanged | 2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN | BlackRock Inc. BLK | 7,794,217 7.800% | 0 (Unchanged) | Filing History |
| 2024-11-04 10:20 am Purchase | 2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN | VANGUARD GROUP INC | 6,864,137 6.830% | 6,864,137 (New Position) | Filing History |
| 2024-10-22 3:24 pm Purchase | 2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN | BlackRock Inc. BLK | 7,794,217 7.800% | 4,005,535 (+105.72%) | Filing History |
| 2024-04-04 7:04 pm Purchase | 2024-03-25 | 13G | Dyne Therapeutics, Inc. DYN | RA CAPITAL MANAGEMENT L.P. | 5,213,661 6.400% | 5,213,661 (New Position) | Filing History |
| 2024-02-14 4:57 pm Purchase | 2023-12-31 | 13G | Dyne Therapeutics, Inc. DYN | CITADEL ADVISORS LLC | 3,072,587 5.000% | 91,263 (+3.06%) | Filing History |
| 2024-02-14 08:39 am Sale | 2023-12-31 | 13G | Dyne Therapeutics, Inc. DYN | Deep Track Capital LP | 2,000,000 3.260% | -2,500,000 (-55.56%) | Filing History |
| 2024-02-12 4:06 pm Sale | 2023-12-31 | 13G | Dyne Therapeutics, Inc. DYN | MPM BIOVENTURES 2018 L.P. | 3,451,303 4.300% | -1,519,596 (-30.57%) | Filing History |